Collectively, these observations underscore the essential role of intact insulin signaling in channeling glucose into metabolic and antioxidative pathways that support HNSCC progression and suggest that targeting this axis may offer a novel therapeutic strategy to counteract the protumorigenic effects of PI3K signaling. The gene discussed is INS; the disease is head and neck squamous cell carcinoma.